Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
19.89
+1.97 (10.99%)
Jan 22, 2026, 4:00 PM EST - Market closed
Pharming Group Employees
Pharming Group had 404 employees as of December 31, 2024. The number of employees increased by 22 or 5.76% compared to the previous year.
Employees
404
Change (1Y)
22
Growth (1Y)
5.76%
Revenue / Employee
$896,718
Profits / Employee
$946
Market Cap
1.36B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2024 | 404 | 22 | 5.76% |
| Dec 31, 2023 | 382 | 50 | 15.06% |
| Dec 31, 2022 | 332 | 55 | 19.86% |
| Dec 31, 2021 | 277 | 15 | 5.73% |
| Dec 31, 2020 | 262 | 50 | 23.58% |
| Jan 1, 2020 | 212 | 29 | 15.85% |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Immatics | 682 |
| AbCellera Biologics | 596 |
| uniQure | 209 |
| Sana Biotechnology | 194 |
| Relay Therapeutics | 188 |
| EyePoint | 165 |
| AnaptysBio | 136 |
| DBV Technologies | 110 |
PHAR News
- 15 days ago - Pharming Group reports preliminary 2025 revenues and announces Investor Day - GlobeNewsWire
- 6 weeks ago - Pharming Group to participate in Oppenheimer Movers in Rare Disease Summit - GlobeNewsWire
- 2 months ago - Pharming Group N.V. (PHAR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Pharming Group to participate in Fireside Chat at Jefferies Global Healthcare Conference in London - GlobeNewsWire
- 3 months ago - Pharming Group to report third quarter 2025 financial results and provide business update on November 6 - GlobeNewsWire
- 3 months ago - Pharming Group announces presentations at 2025 ACAAI Annual Scientific Meeting showcasing new data across rare disease portfolio - GlobeNewsWire
- 3 months ago - Pharming Group provides update on previously announced G&A expense reduction plan - GlobeNewsWire
- 4 months ago - Pharming Group announces U.S. FDA acceptance and Priority Review of supplemental New Drug Application for leniolisib in children with APDS aged 4 to 11 years - GlobeNewsWire